S0003717
Abacavir 60mg disp. tabs/PAC-60
Abacavir Sulfate equivalent to 60mg Abacavir dispersible tablets, pack of 60
Indicative Price : Upon Request
NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org
General Description:
Abacavir Sulfate equivalent to 60mg Abacavir dispersible tablet, bottle pack of 60
Technical Specifications:
Each dispersible tablet contains Abacavir Sulfate equivalent to 60mg Abacavir
Each pack comes with Warning Card
Therapeutic class:
Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI)
Standard shelf life:
2 Years (24 Months)
Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.
Guidelines for use:
For more details, please click the links listed below:
WHO treatment guidelines
and
WHO Essential Medicines Library
or your regional national guidelines
Indications:
Management of HIV infection in children in combination with at least two other antiretroviral drugs. By mouth (oral) PO.
Storage:
Do not store above 30°(86ºF).
Store in tightly closed original container
Keep out of reach and sight of children
Dispensing instructions:
Dispense in original container. Do not repack
Pack comes with Warning Card
Can be taken without regard to food
Tablets are to be dispersed in 5ml water immediately before administration
Regulatory Status:
For latest updates, please click the links listed below:
List of WHO Prequalified Medicines
List of USFDA approved and tentatively approved items
Related Products